Skip to main content
. 2022 Oct 14;12:17212. doi: 10.1038/s41598-022-21074-x

Figure 2.

Figure 2

Association between (A) hemoglobin (HGB)/(B) albumin (ALB) and risk for AKI episodes in patients with aminoglycosides (AGs) use, as compared with non-AGs use, using restricted cubic splines with 5 knots located at 5th, 25th, 50th, 75th, 95th percentiles. Y-axis represents the adjusted hazard ratio for AKI event for any value of serum compared to individuals with 11.6 g/dL of HGB or 3 mg/dL ALB. Dash lines are 95 percent confidence intervals. Dots represent knots.